BMW’s China Headache Deepens as Recall, Leadership Shifts, and a Rare Analyst Upgrade Collide
Published on 07/23/2026 at 03:05 | Redaktion boerse-global.de
BMW is heading into its half-year report on July 30 with a thicket of challenges that would test any automaker: a 30% sales collapse in China, a recall of more than 744,000 vehicles, a management reshuffle, and a stock that has shed over 38% of its value since January. Yet amid the gloom, at least one major bank has flipped bullish, arguing the worst is already priced in.
The China Problem That Won’t Go Away
The numbers from the second quarter tell a stark story. Global deliveries fell 4.9% to 590,962 vehicles, but the headline masks a dramatic regional split. While the US climbed 13% and Europe rose 7.6%, China cratered by 30.2%. That single market has become the dominant drag on the Munich-based group’s performance, and the pain is far from over.
In June, BMW slashed its full-year EBIT margin forecast for the automotive segment from 4-6% to just 1-3%, citing China’s market weakness and one-off costs from restructuring. The market reacted swiftly: the stock has been hovering near its 52-week low of €56.72, set on July 15, closing at €57.62 on Wednesday. That’s a mere 1.59% above the trough. The share now trades nearly 29% below its 200-day moving average, underscoring a persistent downward trend.
A Recall That Spans Model Lines and Years
Adding to the operational strain is one of BMW’s largest recalls in recent memory. Worldwide, 744,234 vehicles must return to workshops, including 42,300 in Germany. The culprit is deposits in the starter relay that can create a fire risk. Thirteen model series from the 2020 to 2026 production years are affected, spanning the 3 Series, 5 Series, X5, Z4, and the electric i3. The breadth of the recall — cutting across combustion, hybrid, and electric powertrains — highlights how deeply the technical flaw runs through BMW’s lineup.
Should investors sell immediately? Or is it worth buying BMW?
A Rare Upgrade in a Sea of Skepticism
On July 22, HSBC analyst Mike Tyndall upgraded BMW from “Hold” to “Buy” with a €71 price target. His reasoning: the June profit warning already reflects the China risks, and the market has discounted them. That puts HSBC in a more optimistic camp than many. Deutsche Bank, for instance, maintained its “Buy” rating with a €90 target on July 14, but analyst Tim Rokossa warned of “significant negative effects” from low volumes and pricing pressure in the coming quarters.
The divergence among analysts mirrors the uncertainty surrounding BMW’s near-term trajectory. The half-year report on July 30 will be the first hard test of whether the lowered margin guidance accurately captures the damage — or if more pain lies ahead.
Washington Adds Regulatory Headwinds
Beyond the showroom floor, BMW faces a political challenge in the US. The Senate Commerce Committee has approved bill S.4429, which tightens rules on foreign ownership of automakers. BMW, along with Mercedes-Benz and Volkswagen, is named as a company potentially exposed to Chinese investor stakes. The bill’s ultimate impact on operations remains unclear, but it adds another layer of uncertainty to a business already navigating trade tensions.
Buybacks, New Leadership, and a Share Structure Overhaul
Despite the headwinds, BMW is pressing ahead with its 2025/2027 share buyback program. Between July 13 and 19, the company repurchased 510,000 common shares on Xetra at an average price of €58.17. A mandatory filing on July 22 confirmed that the group’s stake in its own shares, including indirectly held voting rights, crossed the 3% threshold on July 21, now standing at 3.023% — equivalent to 18,614,921 shares. The ongoing buyback signals management’s commitment to returning capital even as the stock languishes.
On the governance front, the supervisory board appointed Dorothea von Boxberg, formerly CEO of Brussels Airlines, as the new labor director and HR board member effective September 1. She replaces Ilka Horstmeier. The change comes as BMW pushes forward with restructuring measures, which will be detailed at a Capital Market Day on September 29.
Meanwhile, the company completed the conversion of all preference shares into common shares at the end of June, adopting a “one share, one vote” structure. Trading in the preference shares has been halted.
BMW at a turning point? This analysis reveals what investors need to know now.
Bright Spots: German Market Share and Charging Network
Not all news is grim. In Germany, BMW reported 26,119 new registrations in June, an 18.6% year-on-year increase. That pushed its first-half total to 126,766 units, securing the top spot in the premium segment ahead of Mercedes-Benz and Audi. The company also expanded its “BMW Group Charging” network to 1.1 million charging points across Europe, with new app features for cost transparency.
On the technology front, BMW has partnered with Toyota, Bosch, and Repsol on a six-month pilot project to test “Nexa 95,” a gasoline made entirely from renewable sources. Separately, the automaker signed a supply agreement with Sweden’s CTEK to offer a licensed version of the CS ONE (Gen 2) battery charger for the global aftermarket.
The Calendar Ahead
For investors, the next major milestone is July 30, when BMW releases its half-year report and holds an analyst call. The focus will be on how deeply the margin cut has bitten into first-half earnings, whether the China slide is stabilizing, and whether the buyback and restructuring efforts can restore confidence. With the stock near its floor, the report could either validate the pessimism — or, as HSBC believes, mark the beginning of a recovery.
Ad
BMW Stock: New Analysis - 23 July
Fresh BMW information released. What's the impact for investors? Our latest independent report examines recent figures and market trends.
Disclaimer regarding our articles: No investment advice, no buy or sell recommendation. Information on prices, companies, and markets is provided without guarantee; changes are possible at any time. Stock market transactions can lead to substantial losses. Our articles are created and reviewed in whole or in part automatically with the support of AI.
